David Rescott

Stock Analyst at Baird

(3.51)
# 764
Out of 5,182 analysts
81
Total ratings
55.74%
Success rate
3.81%
Average return

Stocks Rated by David Rescott

PROCEPT BioRobotics
Mar 6, 2026
Initiates: Neutral
Price Target: $30
Current: $23.20
Upside: +29.31%
Medtronic
Feb 18, 2026
Maintains: Neutral
Price Target: $103$100
Current: $87.21
Upside: +14.67%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $118$101
Current: $61.79
Upside: +63.46%
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $345$374
Current: $329.77
Upside: +13.41%
SI-BONE
Dec 18, 2025
Maintains: Buy
Price Target: $21$23
Current: $12.84
Upside: +79.13%
Edwards Lifesciences
Dec 16, 2025
Maintains: Neutral
Price Target: $88$87
Current: $77.87
Upside: +11.72%
Haemonetics
Dec 15, 2025
Maintains: Outperform
Price Target: $87$99
Current: $57.32
Upside: +72.71%
LivaNova
Nov 13, 2025
Maintains: Outperform
Price Target: $63$70
Current: $62.78
Upside: +11.50%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111$110
Current: $68.26
Upside: +61.15%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600$575
Current: $450.62
Upside: +27.60%